Log In
BCIQ
Print this Print this
 

VIR-576

  Manage Alerts
Collapse Summary General Information
Company Pharis Biotec GmbH
DescriptionAlpha-1-antitrypsin (AAT; A1AT; SERPINA1) variant
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I/II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV/AIDS
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today